Commonwealth Equity Services
RDHL

Commonwealth Equity Services’s Redhill Biopharma RDHL Stock Holding History

Commonwealth Equity Services’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15
Closed -$2K – 3844
2022
Q4 		$2K Buy
15
+4
+36% +$1.73K ﹤0.01% 3694
2022
Q3 		$5K Sell
11
-1
-8% -$871 ﹤0.01% 3642
2022
Q2 		$10K Hold
12
– – ﹤0.01% 3623
2022
Q1 		$30K Buy
12
+1
+9% +$2.37K ﹤0.01% 3629
2021
Q4 		$28K Sell
11
-1
-8% -$4K ﹤0.01% 3581
2021
Q3 		$53K Buy
+12
New +$81.4K ﹤0.01% 3495
2021
Q1 		– Sell
-16
Closed -$125K – 3451
2020
Q4 		$125K Buy
16
+5
+45% +$44.9K ﹤0.01% 3029
2020
Q3 		$107K Buy
+11
New +$90.2K ﹤0.01% 2867
2020
Q2 		– Sell
-11
Closed -$51K – 2996
2020
Q1 		$51K Buy
+11
New +$55K ﹤0.01% 2681
2019
Q3 		– Sell
-10
Closed -$65K – 2870
2019
Q2 		$65K Hold
10
– – ﹤0.01% 2677
2019
Q1 		$83K Sell
10
-2
-17% -$15.8K ﹤0.01% 2627
2018
Q4 		$66K Buy
+12
New +$91.9K ﹤0.01% 2545

Other funds holding RDHL

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Commonwealth Equity Services's RDHL Position: Q1 2023 in Review

Commonwealth Equity Services sold out of Redhill Biopharma (RDHL) in Q1 2023, closing a stake of 15 shares — an estimated $2K sold.

Commonwealth Equity Services first reported a position in RDHL in Q4 2018 and held it in 12 quarters. The position peaked at $125K in Q4 2020. 16 funds tracked by Wall St. Rank hold RDHL as of Q1 2023.

  • Commonwealth Equity Services reported no remaining Redhill Biopharma position as of Q1 2023 after selling out during the quarter.
  • Commonwealth Equity Services sold 15 Redhill Biopharma shares in Q1 2023, an estimated $2K.
  • Commonwealth Equity Services first reported a position in Redhill Biopharma in Q4 2018 and held it in 12 quarters.
  • Commonwealth Equity Services's Redhill Biopharma position peaked at $125K in Q4 2020.
  • 16 funds tracked by Wall St. Rank held Redhill Biopharma as of Q1 2023.

Based on Commonwealth Equity Services's 13F filing for Q1 2023, filed 11 May 2023.